VC  Longwood Fund

http://www.longwoodfund.com





     Office Locations:

The Prudential Tower
800 Boylston Street, Suite 1555
Boston, MA 02199
Phone: 617-351-2590

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Longwood Fund is a healthcare venture capital firm that founds, manages, and builds biotechnology companies. Longwood's mission is to identify technologies and to found companies that will advance new therapeutics that can not only make a difference in the lives of patients worldwide, but also create significant value for investors. Longwood's portfolio includes Alnara Pharmaceuticals, Inc., which was acquired by Eli Lilly in 2010 for $180 million cash upfront and a $200 million earn-out, and Verastem, Inc., a biotechnology company focused on discovering and developing novel drugs that selectively target cancer stem cells. Members of the Longwood team have founded and built several successful biotechnology companies including Momenta Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Sirtris Pharmaceuticals, Inc., and Alnara Pharmaceuticals, Inc. The firm's first fund, Longwood Founders Fund, L.P., was capped at $85 million when it closed December of 2010.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christoph Westphal M.D., Ph.D. Founder and Partner
    Michelle Dipp M.D., Ph.D. Founder and Partner
    Rich Aldrich Founder and Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/22/2018


      ArcherDX


      CO


      $35,000,000


      Series A


      01/04/2018


      Recros Medica


      CA


      $9,000,000


      


      08/23/2017


      Channel Medsystems


      CA


      $14,100,000


      Series C-1


     

    Portfolio companies include:


      Alnara Pharmaceuticals
        web link


      ArcherDX
        web link


      Axial Biotherapeutics
        web link


      Calithera Biosciences
        web link


      Channel Medsystems
        web link


      Colorescience
        web link


      Flex Pharma
        web link


      FLEXPharma
        web link


      IlluminOssMedical
        web link


      Mitokyne
        web link


      OvaScience
        web link


      PTC Therapeutics
        web link


      Recros Medica
        web link


      Verastem
        web link


     

    Recent News: